NAUT

NAUT

Nautilus Biotechnology Inc

Rev โ€”top 1%5Y
Hold

Nautilus Biotechnology develops a platform to quantify the proteome, including instruments, reagents, and software for protein analysis. Its Nautilus Voyager Platform enables rapid decoding and quantification of proteins in biological samples.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$117today

Score Overview

1 Year
Scoreโ€”
Net Growth4.20%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-12.33%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend20%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-12.33%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend20%
Revenue Consistency

See the full market ranking โ†’

Nautilus Biotechnology Inc fundamental performance

Across Nautilus Biotechnology Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 50M to -$ 59M. Revenue increased in 20% of the years measured; net income in 40%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.90โ€”
1 Year2025-08-12
$ 0.7126.19%
5 Years2021-08-12
$ 7.69-88.30%
All Time2021-06-10
$ 11.00-91.82%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 190K-$ 56M$ 84M
2025$ 0.00-$ 59M$ 103M
2024$ 0.00-$ 70M$ 129M
2023$ 0.00-$ 63M$ 173M
2022$ 0.00-$ 57M$ 184M
IPO2021$ 0.00-$ 50M$ 345M

Explore beyond NAUT

You're looking at Nautilus Biotechnology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies